Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Innovative neurodiagnostic technology set for US trial

EMvision Medical Devices
3:27pm
January 7, 2025
EMV’s innovative brain scanning technology (emuTM) is about to start a pivotal trial to gain US approval for stroke type detection (bleed or clot). If the trial is successful the emuTM is expected to be approved 2HCY26. The key advantages of the device are portability, accessibility, cost and non-ionising radiation. The emuTM is a bedside device for hospital use where management estimates the global addressable market at ~102k units. Looking at the US specialised stroke centres and critical access hospitals, the estimated serviceable market is US$659m. A follow on device will also be trialled for First Responder use with an estimated market of 177k units. Key short term catalysts include commencing recruitment for the emuTM and further real world testing of the First Responder device. Here is a link to a presentation from co-founder and MD, Scott Kirkland.

Close to putting BMG in the rearview mirror

Cooper Energy
3:27pm
April 16, 2024
A solid underlying performance in 3Q24, close to MorgansF/consensus estimates. BMG is now 80% complete, but also expected toward the upper end of guidance range, due to weather and equipment failure causing a week delay. Debottlenecking and upgrading work continues at Orbost, with COE preparing to deploy new nozzles, snowflake packing material, sulphur offtake testing, and the next round of in situ clean trials. The work on BMG is due to be completed by late May, at which point COE transitions into an impressive FCF generator. We maintain an ADD rating, with an unchanged A$0.30ps Target Price.

Charging up the pipeline

LGI
3:27pm
April 16, 2024
LGI’s Investor Day included another encouraging update, as the company reaffirmed its FY24 EBITDA guidance; clearly articulated the short-to-medium term development pipeline; set out its growth strategy; and demonstrated its battery energy storage system capabilities. We increase our FY24-26 EPS forecasts by 5%/12%/7%, reflecting increased battery cycling and LGI’s new Bingo contract. We move to a pure DCF valuation and our 12 month price target increase to A$3.12ps. Upgrade to ADD rec. We have confidence in LGI’s ability to execute on its meaningful development pipeline and are encouraged by the highly attractive unit economics of its battery storage capabilities and the viability of a broader battery rollout. In addition to LGI’s compelling medium term growth opportunity, the business provides investors with exposure to the increasingly important decarbonisation thematic.

Numerous growth opportunities; execution is key

Orica
3:27pm
April 15, 2024
In line with its strategy to expand and grow beyond blasting, ORI has announced acquisitions in both Mining Chemicals and Digital Solutions. While we agree with the strategic rationale, both acquisitions were purchased off private equity and ORI has paid relatively full multiples. We have incorporated the acquisitions and capital raising (A$465m) into our forecasts. With a number of businesses to integrate, it will all come down to execution, which to date, ORI has excelled at under a new management team. Hold maintained.

Unlocking European base and precious upside

Adriatic Metals
3:27pm
April 11, 2024
Adriatic Metals (ADT) is now ramping up production from its world-class Vares underground polymetallic mine in Bosnia, Central Europe. Rich grades and low capital and operating costs drive excellent project economics, >60% EBITDA margins, rapid payback and compelling cash generation. ADT is protected from potential teething issues by supportive off-takers, debt and equity investors who understand Vares’ compelling returns once optimised. We initiate coverage with an Add rating and a A$5.80/ CDI price target and note ADT looks compelling to both equity and strategic investors alike.

1H24 result preview

Bank of Queensland
3:27pm
April 11, 2024
BOQ is scheduled to release its 1H24 result on 17 April. We think cash earnings are likely to fall materially, as is the dividend. REDUCE maintained. Forecast changes immaterial. Target price $5.05 (+3 cps).

Tough 1Q24 but now through the worst of it

Elders
3:27pm
April 8, 2024
Following a challenging 1H24, particularly the 1Q, ELD has provided FY24 EBIT guidance which was materially below consensus estimates. We have revised our FY24 EBIT forecast by 17.7%. The downgrades to consensus will be far greater. However in FY25 and FY26, we have upgraded our forecasts for ELD’s numerous growth projects. Given ELD’s key drivers have improved from the lows and it has a number of growth projects which should underpin solid earnings growth from FY25 onwards, we upgrade to an Add rating following material share price weakness.

Introducing Classic Plus Rewards

Qantas Airways
3:27pm
April 8, 2024
QAN has announced one of the biggest ever expansions of its Frequent Flyer program with the launch of a new flight rewards product called Classic Plus. This new program will give Qantas Frequent Flyers access to over 20m more reward seats and is in addition to its current Classic Reward seats which offers 5m seats. Reflecting the launch of Classic Plus Flight Rewards, QAN has downgraded Loyalty’s FY24 guidance and FY25 guidance was also below consensus. We note that overall, the downgrades at a group level are only minor (1-3%). While this move will impact Loyalty earnings in the near term, Classic Plus will address customer pain points with redeeming points on flights which QAN expects will drive a substantial improvement in member engagement and increased member growth. We also view this as an important step in restoring QAN’s brand health. Importantly, Classic Plus will likely see Loyalty growth materially accelerate from FY26 and will also support the future long term growth of Loyalty with QAN targeting to grow EBIT to A$800-1000m by FY30 (10% CAGR).

A ‘total portfolio of solutions’; now time to execute

Ansell
3:27pm
April 8, 2024
ANN is acquiring the PPE business of Kimberly-Clark for US$640m in cash, representing a reasonable 9.7x EV/EBIT multiple, with third year synergies/tax benefits improving the attractiveness (7.8x). The transaction is being funded via a A$400m private placement (at A$22.45), US$377m new debt bridging facility and up to A$65m SPP. The acquisition is expected to enhance ANN’s global position in attractive, complementary segments, enrich its service capacity, and generate economies of scale, with mid-to-high single digit EPS accretion (ex -synergies; low-teens post-synergies) from close (1QFY25) and ROIC gains in 3 to 5 years. While the multiple appears reasonable and strategic rationale sound, integration is not without risk, especially on the heels of an organisational re-design and ongoing productivity improvements, despite manufacturing being fully outsourced. We raise FY25-26 EPS estimates up to 10.1%, with our DCF/SOTP PT increasing to A$25.61. Hold.

The final part of the simplification journey

Suncorp Group
3:27pm
April 4, 2024
SUN has announced the sale of its NZ Life insurance business (Asteron Life) to Resolution Life for NZ$410m. Analysing the sale is complicated by the recent change in life insurance accounting standards and its impact on earnings. Broadly we think the sale price on a price-to-book multiple basis (~2x) appears reasonable, whilst the earnings multiple of 11x-14.5x (depending on earnings measure) is arguably less full. Nevertheless we remain fans of the continued simplification of SUN’s business. We make relatively nominal earnings changes on the back of this update with SUN FY25F/FY26F EPS lowered by 1%-2%. Our PT rises to A$17.30 on life sale impacts (lost earnings versus additional capital) and a valuation roll-forward.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more